Unknown

Dataset Information

0

Treatment of NRAS-mutated advanced or metastatic melanoma: rationale, current trials and evidence to date.


ABSTRACT: The disease course of BRAF (v-raf murine sarcoma viral oncogene homolog B1)-mutant melanoma has been drastically improved by the arrival of targeted therapies. NRAS (neuroblastoma RAS viral oncogene homolog)-mutated melanoma represents 15-25% of all metastatic melanoma patients. It currently does not have an approved targeted therapy. Metastatic patients receive immune-based therapies as first-line treatments, then cytotoxic chemotherapy like carboplatin/paclitaxel (C/P), dacarbazine (DTIC) or temozolomide (TMZ) as a second-line treatment. We will review current preclinical and clinical developments in NRAS-mutated melanoma, and analyze ongoing clinical trials that are evaluating the benefit of different targeted and immune-based therapies, either tested as single agents or in combination, in NRAS-mutant melanoma.

SUBMITTER: Boespflug A 

PROVIDER: S-EPMC5502949 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Treatment of <i>NRAS</i>-mutated advanced or metastatic melanoma: rationale, current trials and evidence to date.

Boespflug Amélie A   Caramel Julie J   Dalle Stephane S   Thomas Luc L  

Therapeutic advances in medical oncology 20170529 7


The disease course of <i>BRAF</i> (v-raf murine sarcoma viral oncogene homolog B1)-mutant melanoma has been drastically improved by the arrival of targeted therapies. <i>NRAS</i> (neuroblastoma <i>RAS</i> viral oncogene homolog)-mutated melanoma represents 15-25% of all metastatic melanoma patients. It currently does not have an approved targeted therapy. Metastatic patients receive immune-based therapies as first-line treatments, then cytotoxic chemotherapy like carboplatin/paclitaxel (C/P), da  ...[more]

Similar Datasets

| S-EPMC7772871 | biostudies-literature
| S-EPMC7409003 | biostudies-literature
| S-EPMC6256323 | biostudies-literature
| S-EPMC3296083 | biostudies-literature
| S-EPMC8202735 | biostudies-literature
| S-EPMC5040928 | biostudies-literature
| S-EPMC3724529 | biostudies-literature
| S-EPMC3945937 | biostudies-literature
| S-EPMC2787009 | biostudies-literature
| S-EPMC7298618 | biostudies-literature